USA — Eyas Medical Imaging has achieved a remarkable milestone with the installation of their pioneering neonatal Magnetic Resonance Imaging (MRI) system, the Ascent3T, within the neonatal intensive care unit (NICU) at Cincinnati Children’s Hospital.
This groundbreaking technology, although not yet approved for commercial use by the U.S. Food and Drug Administration (FDA), has been selected by Eyas for research studies at Cincinnati Children’s.
With the aim of obtaining FDA 510(k) clearance in the near future, Eyas aspires to grant healthcare providers and their neonatal patients access to this state-of-the-art technology, revolutionizing neonatal diagnostics and transforming care for vulnerable infants.
The Ascent3T represents a quantum leap in neonatal MRI systems, harnessing the power of a 3 Tesla (3T) magnet—a strength previously unexplored in this field.
By utilizing this highly advanced magnet, the Ascent3T offers healthcare professionals an unparalleled diagnostic tool for examining crucial organs such as the brain, lungs, heart, and abdomen in intricate detail.
Neonatal diagnostics will now achieve unmatched accuracy, thereby paving the way for enhanced treatment plans and significantly improved patient outcomes in fragile infants.
As the first health system to adopt the Ascent3T, Cincinnati Children’s Hospital solidifies its position as a pioneer in pediatric healthcare.
Garnering recognition as the nation’s best children’s hospital by U.S. News & World Report and one of America’s Most Innovative Companies by Fortune, Cincinnati Children’s continues to prioritize research, education, and innovation in its mission to enhance child health.
With the addition of the Ascent3T to its arsenal of cutting-edge medical technologies, Cincinnati Children’s reaffirms its commitment to providing world-class care to its youngest and most vulnerable patients.
One of the most significant advantages of the Ascent3T is its ability to be directly installed within the neonatal unit, eliminating the inherent risks associated with transporting delicate newborns to separate MRI locations within the hospital.
With its compact footprint and innovative engineering specifically designed for infant anatomy, this technology guarantees that neonates receive the same level of access and care as adults undergoing conventional MRI procedures.
This groundbreaking solution provides a new dimension to neonatal imaging, benefiting the youngest patients by providing safer and more efficient diagnoses.
A testament to collaboration
The visionary behind the Ascent3T is Dr. Charles Dumoulin, an esteemed MR physicist, and professor of Pediatrics, and Radiology at Cincinnati Children’s.
This remarkable innovation signifies a significant breakthrough in neonatal imaging, transforming the way healthcare professionals evaluate and diagnose newborns.
Dr. Dumoulin expresses his excitement, noting that the Ascent3T brings an unprecedented level of MR imaging and access to their tiniest patients.
By reinventing MRI technology, doctors can now utilize state-of-the-art imaging techniques tailored specifically for infants, leading to better-informed medical decisions and improved neonatal care.
Abram Gordon, the vice president of Cincinnati Children’s Innovation Ventures, highlights the technological leap the Ascent3T represents for the hospital’s most vulnerable patients.
J.P. Nauseef, President, and CEO of JobsOhio, acknowledges the international collaboration that birthed Eyas Medical Imaging, attributing its success to the groundbreaking innovation from Cincinnati Children’s and support from Ohio’s innovation ecosystem.
Funding from the JobsOhio Growth Capital Fund played a crucial role in bringing this revolutionary technology to life.
To spearhead Eyas Medical Imaging’s future endeavors, including the submission of their 510(k) application to the FDA, Matt Storer, an Executive in Residence for CincyTech and former executive at Procter & Gamble, has assumed the role of CEO.
Having played an integral part in Eyas’ management team during the pre-commercialization phase, Matt Storer emphasizes the honor of working with a team dedicated to saving babies’ lives.
For all the latest healthcare industry news from Africa and the World, subscribe to our NEWSLETTER, and YouTube Channel, follow us on Twitter and LinkedIn, and like us on Facebook.
